Diferencia entre revisiones de «Albendazole»
(Text replacement - "5 mg" to "5mg") |
Sin resumen de edición |
||
| (No se muestran 3 ediciones intermedias de 3 usuarios) | |||
| Línea 1: | Línea 1: | ||
==General== | ==General== | ||
*Type: | *Type: [[Antiparasitic]]/Antihelmintic | ||
*Dosage Forms: 200mg | *Dosage Forms: 200mg | ||
*Common Trade Names:Albenza | *Common Trade Names:Albenza | ||
| Línea 47: | Línea 47: | ||
==See Also== | ==See Also== | ||
==References== | ==References== | ||
<references/> | |||
[[Category:Pharmacology]] [[Category:ID]] | |||
[[Category:Pharmacology]] | |||
Revisión actual - 16:39 19 sep 2019
General
- Type: Antiparasitic/Antihelmintic
- Dosage Forms: 200mg
- Common Trade Names:Albenza
Adult Dosing
- Microsporidiosis: 400mg po bid
- neurocysticerosis: < 60 kg: 15mg/kg/day PO BID x 8-30 days, max 800mg/day. >60 kg: 400mg PO BID x 8-30 days
Pediatric Dosing
- neurocysticerosis: < 60 kg: 15mg/kg/day PO BID x 8-30 days, max 800mg/day. >60 kg: 400mg PO BID x 8-30 days
Special Populations
- Pregnancy Rating:C
- Lactation: unknown
- Renal Dosing
- Adult: not defined
- Pediatric: not defined
- Hepatic Dosing
- Adult: not defined
- Pediatric: not defined
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
- leukopenia
- neutropenia
- pancytopenia
- acute renal failure
- hepatitis
- SJS
Common
- abnormal LFT's
- abdominal pain
- nausea/vomiting
- headache
- dizziness
- alopecia
- fever
Pharmacology
- Half-life: 8-12 hour
- Metabolism: liver
- Excretion: bile
- Mechanism of Action: inhibits tublin polymerization